Devendra Hiwase
Devendra Hiwase
Royal Adelaide Hospital, South Australia Health and Medical Research Institute
Verified email at
Cited by
Cited by
Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications
DK Hiwase, V Saunders, D Hewett, A Frede, S Zrim, P Dang, L Eadie, ...
Clinical Cancer Research 14 (12), 3881-3888, 2008
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
AL Brown, P Arts, CL Carmichael, M Babic, J Dobbins, CE Chong, ...
Blood advances 4 (6), 1131-1144, 2020
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
DT Yeung, MP Osborn, DL White, S Branford, J Braley, A Herschtal, ...
Blood, The Journal of the American Society of Hematology 125 (6), 915-923, 2015
Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell …
DK Hiwase, S Hiwase, M Bailey, G Bollard, AP Schwarer
Biology of Blood and Marrow Transplantation 14 (1), 116-124, 2008
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells
E Nievergall, HS Ramshaw, ASM Yong, M Biondo, SJ Busfield, G Vairo, ...
Blood, The Journal of the American Society of Hematology 123 (8), 1218-1228, 2014
Myeloid neoplasms with germline DDX41 mutation
JJC Cheah, CN Hahn, DK Hiwase, HS Scott, AL Brown
International Journal of Hematology 106, 163-174, 2017
Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple …
DK Hiwase, G Bollard, S Hiwase, M Bailey, J Muirhead, AP Schwarer
Cytotherapy 9 (6), 539-547, 2007
Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice
J Puccini, S Shalini, AK Voss, M Gatei, CH Wilson, DK Hiwase, MF Lavin, ...
Proceedings of the National Academy of Sciences 110 (49), 19920-19925, 2013
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
D Singhal, MM Kutyna, R Chhetri, LYA Wee, S Hague, L Nath, SV Nath, ...
Haematologica 102 (12), 2021, 2017
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors
DK Hiwase, DL White, JA Powell, VA Saunders, SA Zrim, AK Frede, ...
Leukemia 24 (4), 771-778, 2010
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
E Nievergall, J Reynolds, CH Kok, DB Watkins, M Biondo, SJ Busfield, ...
Leukemia 30 (6), 1263-1272, 2016
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia
N Shanmuganathan, IS Pagani, DM Ross, S Park, ASM Yong, JA Braley, ...
Blood, The Journal of the American Society of Hematology 137 (9), 1196-1207, 2021
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
CN Hahn, P Venugopal, HS Scott, DK Hiwase
Immunological reviews 263 (1), 257-278, 2015
Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
L Schafranek, E Nievergall, JA Powell, DK Hiwase, T Leclercq, ...
Leukemia 29 (1), 76-85, 2015
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
D Singhal, LYA Wee, MM Kutyna, R Chhetri, J Geoghegan, AW Schreiber, ...
Leukemia 33 (12), 2842-2853, 2019
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
S de Botton, P Fenaux, K Yee, C Récher, AH Wei, P Montesinos, ...
Blood advances 7 (13), 3117-3127, 2023
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
D Singhal, CN Hahn, S Feurstein, LYA Wee, L Moma, MM Kutyna, ...
Leukemia 35 (11), 3245-3256, 2021
Ndfip1-deficient mice have impaired DMT1 regulation and iron homeostasis
NJ Foot, YA Leong, LE Dorstyn, HE Dalton, K Ho, L Zhao, MD Garrick, ...
Blood, The Journal of the American Society of Hematology 117 (2), 638-646, 2011
Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients
DK Hiwase, D Singhal, C Strupp, R Chhetri, MM Kutyna, LA Wee, ...
American journal of hematology 92 (6), 508-514, 2017
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
DK Hiwase, D White, S Zrim, V Saunders, JV Melo, TP Hughes
Leukemia 24 (3), 658-660, 2010
The system can't perform the operation now. Try again later.
Articles 1–20